NASDAQ: ALZN
Alzamend Neuro Inc Stock Ownership - Who owns Alzamend Neuro?

Insider buying vs selling

Have Alzamend Neuro Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Lynne Fahey McGrathDirector2025-10-2330$2.29
$68.70Sell
Milton C. Ault IiiDirector2025-10-0920,397$2.32
$47.38kSell
Milton C. Ault IiiDirector2025-10-08101,394$2.44
$247.20kSell
Milton C. Ault IiiDirector2025-10-0861,743$2.32
$143.24kBuy
Milton C. Ault IiiDirector2025-10-07100,000$2.32
$232.00kBuy
Milton C. Ault IiiDirector2025-10-0757,379$2.49
$142.93kSell
Milton C. Ault IiiDirector2025-10-0682,033$2.45
$201.31kSell
Milton C. Ault IiiDirector2025-10-0365,903$2.44
$160.87kSell
Milton C. Ault IiiDirector2025-10-03100,000$2.32
$232.00kBuy
Milton C. Ault IiiDirector2025-10-0220,686$2.39
$49.52kSell

1 of 5

ALZN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ALZN insiders and whales buy or sell their stock.

ALZN Shareholders

What type of owners hold Alzamend Neuro Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Milton C. Ault Iii1,114.92%35,006,915$88.22MInsider
Jeffrey Oram3.18%100,000$252.00kInsider
Andrew H. Woo3.18%100,000$252.00kInsider
Mark Gustafson1.91%60,000$151.20kInsider
Stephan Jackman1.45%45,500$114.66kInsider
William B. Horne0.96%30,000$75.60kInsider
David J. Katzoff0.18%5,540$13.96kInsider
Ubs Group Ag0.03%902$2.27kInstitution
Tower Research Capital LLC Trc0.03%797$2.01kInstitution
Blackrock Inc0.01%441$1.11kInstitution

1 of 2

ALZN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ALZN0.01%99.99%Net BuyingNet Buying
ACXP50.36%49.64%Net Buying
LYRA4.59%95.41%Net Selling
RNAZ0.87%99.13%
GLTO1.95%98.05%Net Selling

Alzamend Neuro Stock Ownership FAQ

Who owns Alzamend Neuro?

Alzamend Neuro (NASDAQ: ALZN) is owned by 0.07% institutional shareholders, 1,125.78% Alzamend Neuro insiders, and 0.00% retail investors. Milton C. Ault Iii is the largest individual Alzamend Neuro shareholder, owning 35.01M shares representing 1,114.92% of the company. Milton C. Ault Iii's Alzamend Neuro shares are currently valued at $88.22M.

If you're new to stock investing, here's how to buy Alzamend Neuro stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.